tiprankstipranks
Advertisement
Advertisement

HK:1244 Stock Latest News

3D Medicines Revamps Board as Finance Veteran Joins After Non-Executive Director Steps Down
Company Announcements3D Medicines Revamps Board as Finance Veteran Joins After Non-Executive Director Steps Down
9d ago
1244
3D Medicines Details Board and Committee Structure
PremiumCompany Announcements
3D Medicines Details Board and Committee Structure
9d ago
1244
3D Medicines Updates Hong Kong Process Agent and Moves Principal Office
PremiumCompany Announcements
3D Medicines Updates Hong Kong Process Agent and Moves Principal Office
12d ago
1244
3D Medicines Wins Arbitration Against SELLAS, Licence Deal Intact
PremiumCompany Announcements
3D Medicines Wins Arbitration Against SELLAS, Licence Deal Intact
20d ago
1244
3D Medicines Shareholders Approve All AGM Resolutions, Expand Capital Mandates
PremiumCompany Announcements
3D Medicines Shareholders Approve All AGM Resolutions, Expand Capital Mandates
2M ago
1244
3D Medicines consolidates company secretary and authorised representative roles
PremiumCompany Announcements3D Medicines consolidates company secretary and authorised representative roles
2M ago
1244
3D Medicines Sets 2026 AGM to Approve Results, Board Changes and Share Mandate
Premium
Company Announcements
3D Medicines Sets 2026 AGM to Approve Results, Board Changes and Share Mandate
2M ago
1244
3D Medicines’ Envafolimab Trial in Biliary Tract Cancer to Headline 2026 ASCO Meeting
Premium
Company Announcements
3D Medicines’ Envafolimab Trial in Biliary Tract Cancer to Headline 2026 ASCO Meeting
3M ago
1244
3D Medicines Completes Phase III Envafolimab Lung Cancer Trial Enrollment Ahead of Schedule
PremiumCompany Announcements
3D Medicines Completes Phase III Envafolimab Lung Cancer Trial Enrollment Ahead of Schedule
3M ago
1244
3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
PremiumCompany Announcements
3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
5M ago
1244
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
PremiumCompany Announcements
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
5M ago
1244
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
PremiumCompany Announcements
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
5M ago
1244
3D Medicines Moves Envafolimab Toward Full Approval in China
PremiumCompany Announcements3D Medicines Moves Envafolimab Toward Full Approval in China
6M ago
1244
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
Premium
Company Announcements
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
7M ago
1244
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
Premium
Company Announcements
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
7M ago
1244
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
PremiumCompany Announcements
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
8M ago
1244
3D Medicines’ New Cancer Pain Study: Potential Market Impact
PremiumCompany Announcements
3D Medicines’ New Cancer Pain Study: Potential Market Impact
10M ago
1244
3D Medicines Reports Strong Progress and Global Expansion in H1 2025
PremiumCompany Announcements
3D Medicines Reports Strong Progress and Global Expansion in H1 2025
12M ago
1244
3D Medicines Administers First Dose of Novel Cancer Drug
PremiumCompany Announcements
3D Medicines Administers First Dose of Novel Cancer Drug
12M ago
1244
3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy Development
PremiumCompany Announcements3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy Development
12M ago
1244
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration
Premium
Company Announcements
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration
12M ago
1244
3D Medicines Inc. Announces Withdrawal of Legal Proceedings
Premium
Company Announcements
3D Medicines Inc. Announces Withdrawal of Legal Proceedings
1y ago
1244

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >